Robert Peter Budetti

Amministratore Delegato presso Feighner Research Institute

79 anni

Health Services

Health Technology

Consumer Services

Posizioni attive di Robert Peter Budetti

Società	Posizione	Inizio	Fine
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Direttore operativo	05/02/2010	-
Feighner Research Institute	Amministratore Delegato	05/02/2010	-

Società	Posizione	Inizio	Fine
Quintiles, Inc. (California) Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA.	Corporate Officer/Principal	02/01/1994	02/01/1994
Institute for Creation Research	Direttore operativo	02/01/1992	02/01/1992
	Direttore Finanziario/CFO	02/01/1992	02/01/1992
	Fondatore	02/01/1992	02/01/1992

Harvard University

Undergraduate Degree

Distribuzione geografica

Stati Uniti

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	4
Quintiles, Inc. (California) Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA.	Health Services
Tetragenex Pharmaceuticals, Inc. Tetragenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetragenex Pharmaceuticals, Inc. operates as a biotechnology company. It develops and commercializes proprietary pharmaceutical products for use in treatment resistant depression and other central nervous system diseases in the United States. The firm's principal product is Nemifitide, an antidepressant compound, which is in Phase II clinical trials for the treatment of depression, anxiety, and other central nervous system disorders. The company was founded in 1989 and is headquartered in Syosset, NY.	Health Technology
Institute for Creation Research
Feighner Research Institute